Literature DB >> 1689887

The effects of FK 506 on renal function after liver transplantation.

J McCauley1, J Fung, A Jain, S Todo, T E Starzl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689887      PMCID: PMC2903864     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  10 in total

1.  Effect of FK506 in experimental organ transplantation.

Authors:  S Todo; N Murase; Y Ueda; L Podesta; P ChapChap; D Kahn; K Okuda; O Imventarza; A Casavilla; J Demetris
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

2.  Immunopharmacology of FK-506.

Authors:  R E Morris; E G Hoyt; M P Murphy; R Shorthouse
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

3.  The effect of FK-506 on hyperacute rejection in presensitized rats.

Authors:  L Makowka; F Chapman; S Qian; A Zerbe; P H Lee; N Murase; R Saunders; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

4.  Pathological studies in canine and baboon renal allograft recipients immunosuppressed with FK-506.

Authors:  S Thiru; D S Collier; R Calne
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

5.  A highly sensitive method to assay FK-506 levels in plasma.

Authors:  K Tamura; M Kobayashi; K Hashimoto; K Kojima; K Nagase; K Iwasaki; T Kaizu; H Tanaka; M Niwa
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

Review 6.  Cyclosporine nephrotoxicity.

Authors:  B D Myers
Journal:  Kidney Int       Date:  1986-12       Impact factor: 10.612

7.  Renin-angiotensin-aldosterone system in cyclosporin A-treated renal allograft recipients.

Authors:  B Stanek; J Kovarik; W Buschbeck; K Silberbauer; W Pinggera
Journal:  Nephron       Date:  1985       Impact factor: 2.847

8.  Renin-angiotensin-aldosterone system and vasopressin in cyclosporine-treated renal allograft recipients.

Authors:  B Stanek; J Kovarik; S Rasoul-Rockenschaub; K Silberbauer
Journal:  Clin Nephrol       Date:  1987-10       Impact factor: 0.975

Review 9.  FK-506--how much potential?

Authors:  A W Thomson
Journal:  Immunol Today       Date:  1989-01

10.  FK 506 for liver, kidney, and pancreas transplantation.

Authors:  T E Starzl; S Todo; J Fung; A J Demetris; R Venkataramman; A Jain
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

  10 in total
  27 in total

1.  Effect of renal ischemia on plasma levels of FK 506 in rats.

Authors:  M Sakr; G Zetti; J Gavaler; H Farghali; R Venkataramanan; G Carrieri; T Starzl; D Van Thiel
Journal:  Transplant Proc       Date:  1992-02       Impact factor: 1.066

2.  Changes in renal function after liver transplantation under FK 506.

Authors:  J McCauley; J J Fung; S Todo; A Jain; P Deballi; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

3.  Strategy of FK 506 therapy in liver transplant patients: effect of graft function.

Authors:  K M Abu-Elmagd; J J Fung; M Alessiani; A Jain; S Takaya; R Venkataramanan; V S Warty; W Shannon; S Todo; A Tzakis
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

4.  Pharmacokinetics of cyclosporine and nephrotoxicity in orthotopic liver transplant patients rescued with FK 506.

Authors:  A B Jain; R Venkataramanan; J Fung; G Burckart; J Emeigh; W Diven; V Warty; K Abu-Elmagd; S Todo; M Alessiani
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

5.  Renal function after conversion from cyclosporine to FK 506 in liver transplant patients.

Authors:  J McCauley; J J Fung; H Brown; P Deballi; A Jain; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

6.  Kidney transplantation under FK 506 immunosuppression.

Authors:  R Shapiro; M Jordan; J Fung; J McCauley; J Johnston; Y Iwaki; A Tzakis; T Hakala; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

7.  Glycemia and insulin need following FK 506 rescue therapy in liver transplant recipients.

Authors:  L Mieles; R D Gordon; D Mintz; R M Toussaint; O Imventarza; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

8.  The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver.

Authors:  K Abu-Elmagd; J J Fung; M Alessiani; A Jain; R Venkataramanan; V S Warty; S Takaya; S Todo; W D Shannon; T E Starzl
Journal:  Transplantation       Date:  1991-07       Impact factor: 4.939

9.  Tacrolimus analysis: a comparison of different methods and matrices.

Authors:  V Warty; S Zuckerman; R Venkataramanan; J Lever; J Chao; T Mckaveney; J Fung; T Starzl
Journal:  Ther Drug Monit       Date:  1995-04       Impact factor: 3.681

Review 10.  Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.